Golden State Wealth Management LLC lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 151.1% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,879 shares of the medical equipment provider's stock after purchasing an additional 2,334 shares during the period. Golden State Wealth Management LLC's holdings in Intuitive Surgical were worth $1,922,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also added to or reduced their stakes in the company. Castleark Management LLC lifted its holdings in shares of Intuitive Surgical by 3.4% during the fourth quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock worth $47,221,000 after buying an additional 2,990 shares in the last quarter. FourThought Financial Partners LLC acquired a new stake in Intuitive Surgical in the 4th quarter worth about $1,158,000. Longbow Finance SA bought a new stake in Intuitive Surgical in the 4th quarter valued at about $4,431,000. Ewing Morris & Co. Investment Partners Ltd. bought a new stake in Intuitive Surgical in the 4th quarter valued at about $454,000. Finally, Whalerock Point Partners LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $209,000. 83.64% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
ISRG has been the subject of several recent research reports. Evercore ISI cut their price target on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research note on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft downgraded Intuitive Surgical from a "hold" rating to a "sell" rating and cut their target price for the company from $515.00 to $440.00 in a research report on Monday, June 9th. Royal Bank Of Canada decreased their price target on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Citigroup reissued a "buy" rating and issued a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Finally, BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the company a "buy" rating in a research report on Monday, April 14th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $588.95.
Read Our Latest Stock Report on Intuitive Surgical
Insider Transactions at Intuitive Surgical
In other news, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction on Monday, April 28th. The shares were sold at an average price of $515.91, for a total value of $96,991.08. Following the completion of the sale, the executive vice president now owns 5,224 shares in the company, valued at $2,695,113.84. The trade was a 3.47% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Mark Brosius sold 215 shares of the stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $549.06, for a total transaction of $118,047.90. Following the transaction, the senior vice president now directly owns 1,768 shares in the company, valued at $970,738.08. This trade represents a 10.84% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 4,998 shares of company stock valued at $2,611,577. Corporate insiders own 0.70% of the company's stock.
Intuitive Surgical Trading Up 2.4%
ISRG stock traded up $12.56 during trading on Thursday, hitting $534.19. The company had a trading volume of 1,965,145 shares, compared to its average volume of 1,672,340. Intuitive Surgical, Inc. has a one year low of $413.82 and a one year high of $616.00. The business has a 50-day moving average of $530.03 and a 200-day moving average of $536.86. The stock has a market cap of $191.46 billion, a PE ratio of 78.33, a PEG ratio of 5.53 and a beta of 1.67.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. The company had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same period in the prior year, the company posted $1.50 earnings per share. Research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.
Intuitive Surgical Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.